| Tranexamic Acid During Telescoping Nail Application In Osteogenesis Imperfecta (NCT05321199) | Assiut University | 2022-05-01 |
| Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis Imperfecta (NCT05312697) | Ultragenyx Pharmaceutical Inc | 2022-04-28 |
| Setrusumab vs Placebo for Osteogenesis Imperfecta (NCT05125809) | Ultragenyx Pharmaceutical Inc | 2022-02-21 |
| Resilience and Coping in a Rare Skeletal Disease Population to Face Coronavirus (COVID-19) Outbreak Distress: a Longitudinal Study (NCT04844697) | Istituto Ortopedico Rizzoli | 2021-05-12 |
| Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta (NCT04545554) | Amgen | 2021-01-21 |
| Results of Telescoping Nail In OI; a Case Series (NCT04694144) | Assiut University | 2020-12-01 |
| Osteogenesis Imperfecta Blood Pressure Study (NCT04169568) | Nemours Children's Clinic | 2019-11-15 |
| Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta (NCT04119388) | Hospices Civils de Lyon | 2019-11-04 |
| Effects of Bisphosphonates on OI-Related Hearing Loss (NCT04152551) | Hospital for Special Surgery, New York | 2019-11-02 |
| Epigenetic Regulation of Osteogenesis Imperfecta Severity : miROI Study (NCT04009733) | Hospices Civils de Lyon | 2019-10-03 |
| Boost Brittle Bones Before Birth (NCT03706482) | Karolinska Institutet | 2019-08-12 |
| Experimental Evaluation of Back Braces for the Treatment of Spinal Deformity Produced With 3D Printing Technology (NCT04282408) | IRCCS Eugenio Medea | 2019-07-09 |
| Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones (NCT04623606) | Christian Medical College, Vellore, India | 2019-05-20 |
| Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation (NCT03575221) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2018-07-30 |
| Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta (NCT03064074) | Baylor College of Medicine | 2017-11-15 |
| Pregnancy in Osteogenesis Imperfecta (OI) Registry (NCT03072303) | University of South Florida | 2017-06-16 |
| Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta? (NCT03208582) | Sheffield Children's NHS Foundation Trust | 2017-04-01 |
| Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid (NCT03735537) | University of Edinburgh | 2016-11-01 |
| Dental Malocclusion and Craniofacial Development in OI (NCT02934451) | Baylor College of Medicine | 2016-08-01 |
| Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2 (NCT02793063) | University of South Florida | 2016-06-01 |
| High Resolution Thermal Imaging to Identify Vertebral Fractures in Children and Young People With Osteogenesis Imperfecta (NCT04231916) | Sheffield Children's NHS Foundation Trust | 2015-10-23 |
| Urinary Biomarkers of OI Pathobiology (NCT02531087) | Baylor College of Medicine | 2015-08-17 |
| Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI (NCT02352753) | Amgen | 2015-06-24 |
| BBD Longitudinal Study of Osteogenesis Imperfecta (NCT02432625) | Baylor College of Medicine | 2015-06-01 |
| NGS Strategy Effectiveness in Molecular Diagnosis (NCT03557567) | Istituto Ortopedico Rizzoli | 2014-09-29 |
| Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta (NCT02172885) | Hospital de Cruces | 2014-04-01 |
| Registry of Osteogenesis Imperfecta (NCT04115774) | Luca Sangiorgi | 2013-06-28 |
| Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab (NCT01799798) | University of Cologne | 2013-02-01 |
| The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta (NCT01679080) | University of Aarhus | 2012-11-01 |
| Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta (NCT01713231) | Louis-Nicolas Veilleux Ph.D. | 2012-09-01 |
| Nutritional Interventional in Pediatric Patients With Osteogenesis Imperfecta (NCT03841188) | Hospital de Clinicas de Porto Alegre | 2012-02-08 |
| Whole Body Vibration Training in Children With Osteogenesis Imperfecta and Limited Mobility (NCT03029312) | Birmingham Women's and Children's NHS Foundation Trust | 2012-01-17 |
| Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman Spectroscopy (NCT02814591) | University College, London | 2011-10-01 |
| An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta (NCT00982124) | Shriners Hospitals for Children | 2007-10-01 |
| Prevention of Post Operative Bone Loss in Children (NCT00655681) | University of New Mexico | 2007-09-01 |
| Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta (NCT02303873) | Peking Union Medical College Hospital | 2007-03-01 |
| Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta (NCT00131469) | Oregon Health and Science University | 2005-06-01 |
| Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children (NCT00106028) | Warner Chilcott | 2004-11-01 |
| Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta (NCT00131118) | Novartis Pharmaceuticals | 2004-07-01 |
| Evaluation and Treatment of Patients With Connective Tissue Disease (NCT00076830) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2004-05-18 |
| Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study (NCT00187018) | St. Jude Children's Research Hospital | 2004-03-01 |
| Bisphosphonate Treatment of Osteogenesis Imperfecta (NCT00063479) | Novartis Pharmaceuticals | 2003-06-01 |
| Pamidronate to Treat Osteogenesis Imperfecta in Children (NCT00005901) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2000-06-01 |
| Bisphosphonate Therapy for Osteogenesis Imperfecta (NCT00159419) | Indiana University | 1999-08-01 |
| Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation (NCT00705120) | St. Jude Children's Research Hospital | 1995-11-01 |
| Growth Hormone Therapy in Osteogenesis Imperfecta (NCT00001305) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1991-11-05 |